Evolution of TP53 abnormalities during CLL disease course is associated with telomere length changes

OLBERTOVA, H., K. PLEVOVA, S. PAVLOVA, J. MALCIKOVA, J. KOTASKOVA, K. STRANSKA, M. SPUNAROVA, M. TRBUSEK, V. NAVRKALOVA, B. DVORACKOVA, N. TOM, K. PAL, M. JAROSOVA, Y. BRYCHTOVA, A. PANOVSKA, M. DOUBEK, S. POSPISILOVA
Evolution of TP53 abnormalities during CLL disease course is associated with telomere length changes. BMC Cancer. 2022, 22(1), 137, ISSN: 1471-2407, PMID: 35114947,